Trump administration readies tariffs for imported drugs
WASHINGTON — The Trump administration has prepared an order that would impose a 100% tariff on imports of…
White House shares legislative text of MFN drug bill with drugmakers
WASHINGTON — The White House has drafted legislative text for its drug pricing policy, and officials are in…
Robert Califf says political influence is a ‘serious problem’ at FDA| STAT
Hundreds of individualized treatments for rare diseases could become available over the next decade — but only if…
Trump gets more credit than Biden for trying to lower drug prices
WASHINGTON — Reining in drug prices has been a priority for both the Trump and Biden administrations. Trump…
Are vaccines a political winner? A look at the MAGA, MAHA divide
WASHINGTON — White House officials are steering the Trump administration away from vaccine reform, fearing the political consequences…
Blue Cross Blue Shield study says AI upcoding is driving up prices
Since last summer, health insurers have been telling investors that hospitals’ use of artificial intelligence tools for medical…
Gilead to buy Arcellx in nearly $8B deal
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Hims & Hers Health addresses scrutiny of GLP-1 compounding| STAT
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
Pharma companies turn to Trump-connected firms for FDA lobbying
Pharmaceutical giants, seeing a wave of new risks and potential rewards in President Trump’s second term, are boosting…
Key study of Grail’s cancer detection test fails in setback for company
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT…
As Health insurers embrace AI, providers say it undermines trust
Casey Ross covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and…
Prasad overruled FDA staff to reject Moderna flu vaccine application
WASHINGTON — Top Food and Drug Administration official Vinay Prasad overruled the agency’s reviewers when he refused to accept…